Skip to main navigation
Harrow Health

> Main Menu

About Our Company Our History Corporate Values Leadership Team Mission Work Corporate Transparency
Careers
Contact
Investors Overview News Events Letters to Stockholders Corporate Transparency Report Corporate Governance SEC Filings & Financials Stock Information Investor Resources

> Main Menu

About
Our Company Our History Corporate Values Leadership Team Mission Work Corporate Transparency
Careers Contact
Investors
Overview News Events Letters to Stockholders Corporate Transparency Report Corporate Governance SEC Filings & Financials Stock Information Investor Resources

Press Releases

February 15, 2022
Harrow Health to Present at Aegis Virtual Conference
February 8, 2022
Harrow Health Publishes Corporate Transparency Report
January 10, 2022
Harrow Health to Participate in H.C. Wainwright BioConnect Conference
January 4, 2022
Melt Pharmaceuticals Submits INDs for MELT‑210 and MELT-400 to FDA

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3
Displaying 21 - 24 of 24
Harrow Health

Address

102 Woodmont Blvd., Suite 610
Nashville, TN 37205

Phone

(615) 733 4730
(615) 733 4737 (Investor Relations)

Social

LinkedIn

© 2022 Harrow Health, Inc.

> Footer

Privacy Policy Cookie Notice